Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants



Status:Completed
Conditions:Post-Surgical Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:12 - 17
Updated:10/28/2017
Start Date:June 29, 2015
End Date:September 12, 2016

Use our guide to learn which trials are right for you!

An Open Label Evaluation of the Safety and Clinical Utility of the Active, Separated System With Enhanced Controller (SSEC) Fentanyl 40 mcg for the Management of Acute Postoperative Pain in Pediatric Patients 12 to Less Than 18 Years of Age

The objective of this study is to evaluate the safety and clinical utility of the active,
SSEC fentanyl 40 micrograms (mcg) for the management of acute, postoperative pain in
pediatric participants.

An open label evaluation of the safety and clinical utility of the active, SSEC fentanyl 40
mcg for the management of acute postoperative pain in pediatric participants 12 to less than
18 years of age.

Inclusion Criteria:

- Participants whose parent(s) or guardian(s) have/has signed and dated an informed
consent form for the participant to participate in the study, or participants who have
provided written assent to participate in the study

- Male or female inpatients, age 12 to <18 years of age inclusive on the day of surgery

- Participants capable of understanding and cooperating with the requirements of the
study, including being able to report their pain intensity using the 11-point Numeric
Rating Scale and operate the SSEC

- American Society of Anesthesiologists physical status I, II or III

- Body weight of at least 40.0 kilogram (kg)

- Postoperative participants who have undergone general or regional anesthesia for
abdominal, pelvic/genitourinary, orthopedic, or thoracic surgery

- Postoperative participants who have been observed during recovery and are expected to
remain hospitalized and have pain requiring parenteral opioids (that is, intravenous
[IV] patient-controlled anesthesia) for the next 24 hours or longer

- Participants who are awake and breathing spontaneously with a respiratory rate of 14
to 18 breaths per minute, peripheral capillary oxygen saturation ≥93% (with or without
supplemental oxygen), and able to answer questions and follow commands

- Participants who have been observed during recovery, who are awake, able to answer
questions and follow commands, and who have been comfortable for at least 30 minutes,
with a pain intensity score ≤4 (numeric rating scale 0-10), with or without titration
to comfort with IV opioids

Exclusion Criteria:

- Participants who have undergone any surgery on the airway, head, or neck

- Participants who received an extended-release opioid within 48 hours prior to Hour 0
or who are expected to have postoperative analgesia supplied by a continuous regional
technique or participant-controlled epidural analgesia

- Participants with a history of allergy or hypersensitivity to fentanyl, skin
adhesives, and/or cetylpyridinium chloride

- Participants who are expected to require intensive care or will likely require
additional surgical procedures within 36 hours

- Participants who received intra-operative and/or postoperative administration of
opioids other than morphine, hydromorphone, fentanyl, sufentanil, or alfentanil.
Exception: If there are no medical contraindications, meperidine (pethidine) up to 0.5
milligram/kg IV is permitted during recovery for shivering

- Participants who require airway support (nasal or oropharyngeal airway intubation, or
laryngeal mask airway at the time of final baseline assessments (that is, at the time
of IONSYS application [Hour 0])

- Participants who are known or suspected to be opioid tolerant, have a history of
opioid dependence within 3 months before the start of the study, or who are known to
have used illicit drugs or alcohol within 14 days of the start of the study

- Participants with active generalized skin disorders or active local skin disease that
precludes SSEC application to the chest or upper arm

- Participants with any coexisting major medical conditions that are likely to interfere
with study procedures including, but not limited to, psychiatric conditions, chronic
depression, suicidal ideation, autism

- Positive pregnancy test for any female
We found this trial at
11
sites
Palo Alto, California 94304
Principal Investigator: Elliot Krane, MD
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials
1611 Northwest 12th Avenue
Miami, Florida 33136
?
mi
from
Miami, FL
Click here to add this to my saved trials
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Principal Investigator: Arjunan Ganesh, MBBS
Phone: 215-590-9114
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
4401 Penn Avenue
Pittsburgh, Pennsylvania 15224
412-692-5325
Principal Investigator: Mihaela Visoiu, MD
Children's Hospital of Pittsburgh of UPMC UPMC is one of the leading nonprofit health systems...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
1405 Clifton Road NE
Atlanta, Georgia 30322
404-785-6000
Children's Healthcare of Atlanta Whether treating a toddler in an emergency or supporting a teen...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Baltimore, Maryland 21287
Principal Investigator: Myron Yaster, MD
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
1935 Medical District Dr
Dallas, Texas 75235
(214) 456-7000
Principal Investigator: Alan C Farrow-Gillespie, MD
Children's Medical Center of Dallas Children's Medical Center is private, not-for-profit, and is the fifth-largest...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
9000 W Wisconsin Ave #270
Milwaukee, Wisconsin 53226
(414) 266-2000
Principal Investigator: Steven Weisman, MD
Children's Hospital of Wisconsin Nothing matters more than our children. At Children's Hospital of Wisconsin,...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
325 9th Ave
Seattle, Washington 98104
(206) 744-3300
Principal Investigator: Sanjay Bhananker, MD
Phone: 206-354-3360
Harborview Medical Center Harborview Medical Center is the only designated Level 1 adult and pediatric...
?
mi
from
Seattle, WA
Click here to add this to my saved trials
325 9th Ave
Seattle, Washington 98104
(206) 744-3300
Harborview Medical Center Harborview Medical Center is the only designated Level 1 adult and pediatric...
?
mi
from
Seattle, WA
Click here to add this to my saved trials